Strong quality and regulatory teams are fundamental to medical device companies.
They understand the product, the organisation, its history, and the practical realities behind the quality management system. They are often the people connecting product development, clinical activities, post-market responsibilities, regulatory requirements, and day-to-day company operations.
External QA/RA support should not replace that expertise.
At its best, it does something different. It provides additional capacity, specialist knowledge, and an independent perspective when these are useful. This might mean reviewing an area before an external audit, supporting the correction of findings, taking responsibility for a defined documentation project, or helping the internal team interpret and implement a regulatory requirement that falls outside its everyday focus.
The objective is to strengthen the work already being done inside the organisation.
A fresh perspective on familiar processes
Internal teams know their systems better than anyone else. That is one of their greatest strengths, but it can also make certain issues more difficult to see.
When the same people work with the same procedures and documentation every day, established ways of working naturally become familiar. A process may make perfect sense internally because everyone understands its history and context, even if some of that logic is not fully visible in the documentation.
An external review introduces a different perspective.
This can be especially useful in internal audits, gap assessments, technical documentation reviews, or preparations for notified body and authority interactions. The purpose is not simply to search for nonconformities. It is to test whether the system, documentation, and rationale remain clear and robust when viewed by someone who was not involved in creating them.
Often, the result is not a major finding but a set of practical improvement opportunities that make the system stronger before it is assessed externally.
Preparing before the external reviewer arrives
An independent review can be particularly valuable before an audit, technical documentation assessment, or regulatory submission.
At this stage, internal teams may already have spent considerable time working with the same documents. Bringing in another specialist can help challenge assumptions, identify inconsistencies, and confirm that evidence supports the conclusions being made.
This could involve reviewing an ISO 13485 quality management system, assessing MDR or IVDR readiness, checking technical documentation, or taking a closer look at areas such as clinical evaluation, PMS, PMCF, PSUR, risk management, or change control.
The aim is not necessarily to rebuild anything. Often, it is simply to identify where clarification, additional evidence, or a more consistent approach would strengthen the existing work.
That independent check can provide additional confidence before the documentation reaches an auditor, notified body, authority, or other external reviewer.
When audit findings need to become real improvements
Receiving an audit finding is only the beginning of the corrective process.
The next steps may include root-cause analysis, determining the extent of the issue, defining corrective actions, updating procedures or technical documentation, implementing changes, training personnel, and ultimately demonstrating that the action has been effective.
This follow-up work can become substantial, particularly when several findings affect interconnected processes.
External QA/RA support can help provide structure during this phase. A specialist can work alongside the internal team to analyse the finding, determine what needs to change, prepare or update documentation, and ensure that corrective actions address the underlying issue rather than only the immediate observation.
The internal team still owns the process and the decisions. External support provides additional hands and experience to help move the work from finding to sustainable improvement.
Specialist expertise does not always need to sit in-house
The scope of modern QA/RA work is broad.
A team may be highly experienced in MDR technical documentation and quality management but encounter an FDA submission only occasionally. Another organisation may have strong regulatory expertise but need additional support with clinical evaluation, software compliance, cybersecurity, or a specific post-market activity.
Maintaining deep in-house expertise in every regulatory subject is not realistic or necessary for many organisations.
External specialists can be brought in for defined areas when the need arises. This could include a CER update, PMS or PSUR work, an internal audit, remediation of technical documentation, an FDA Q-Submission or market entry project, software medical device requirements, or interpretation of changing MDR or IVDR expectations.
The same principle applies to the PRRC role. Regulatory oversight does not require the PRRC to personally perform every specialist activity. Appropriate external expertise can support individual workstreams while responsibility, oversight, and decision-making remain clearly within the organisation.
Keeping pace with a changing regulatory environment
Quality and regulatory systems also need to evolve.
MDR and IVDR implementation continues to develop, digital regulatory infrastructure such as EUDAMED is becoming part of routine regulatory work, and companies operating internationally need to consider developments such as FDA QMSR alongside new expectations affecting software, cybersecurity, and AI.
For an internal team, keeping track of every development while also managing everyday QA/RA responsibilities can require significant time.
External specialists often work across different companies, technologies, and regulatory situations. This provides exposure to a wider range of practical questions and implementation approaches that can complement the organisation’s own experience.
The value is not simply knowing that a requirement has changed. It is understanding what the change means for the company’s existing processes, documentation, and products, and determining whether anything actually needs to be updated.
Additional capacity when priorities overlap
External expertise is also valuable for a much simpler reason: sometimes there is more work than there are available hours.
Audits, technical documentation updates, clinical evaluation activities, CAPA follow-up, regulatory submissions, and post-market reporting do not always arrive conveniently one at a time.
Even a well-resourced team can experience periods when several priorities overlap.
In these situations, support can be very focused. A company may need help with one internal audit, one CER, a set of audit findings, a technical file review, or a submission project. Another organisation may need temporary QA/RA capacity for a few months while several projects move forward simultaneously.
External support does not have to mean outsourcing a function. It can simply mean bringing in the right expertise for a defined need.
Working alongside the internal team
The most effective QA/RA support is collaborative.
The internal team brings product knowledge, organisational context, and responsibility for the quality and regulatory system. The external specialist brings additional experience, capacity, and an independent point of view.
Clear responsibilities are important, but so is communication. The purpose should be to strengthen the organisation’s own processes and capabilities rather than creating a parallel system around them.
This approach can be useful for established quality organisations as well as smaller companies with limited QA/RA resources. The scope of support may differ, but the principle remains the same: use external expertise where it adds value and keep ownership and decision-making where they belong.
Support where it is needed
There is no single model for external QA/RA support.
Sometimes the most valuable contribution is an independent pair of eyes before an audit. Sometimes it is hands-on help correcting findings or updating documentation. In other situations, a team needs specialist expertise for an FDA project, clinical evaluation, software compliance, or a regulatory change it encounters only occasionally.
The common factor is that external support should complement the people already responsible for quality and regulatory work.
At MDS, we work alongside internal QA/RA teams, PRRCs, and manufacturers with practical support ranging from focused reviews and individual work packages to broader regulatory and quality projects.
The goal is not to replace existing expertise. It is to strengthen it when additional capacity, specialist knowledge, or an independent perspective can help.
If your team has a pending QA/RA project, an upcoming audit, findings that need follow-up, documentation requiring review, or simply an area where an additional specialist perspective would be useful, MDS is available to support you.
You can contact us at sales@mdsfinland.com or via Book a Meeting.
